Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
Author:
Affiliation:
1. Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;
2. Department of Pathology, Johns Hopkins University, Baltimore, MD; and
3. Cerus Corporation, Concord, CA
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/110/1/186/480732/zh801307000186.pdf
Reference33 articles.
1. The B7 family revisited.;Greenwald;Annu Rev Immunol,2005
2. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis [published erratum appears in J Immunol. 2006;176:5683].;Zhu;J Immunol,2006
3. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.;Curiel;Nat Med,2003
4. In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses.;Shin;J Exp Med,2005
5. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.;Hirano;Cancer Res,2005
Cited by 163 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance immunotherapy for pancreatic cancer;Acta Biomaterialia;2024-01
2. Unraveling the Role of Epithelial Cells in the Development of Chronic Rhinosinusitis;International Journal of Molecular Sciences;2023-09-18
3. Evolving strategies and application of proteins and peptide therapeutics in cancer treatment;Biomedicine & Pharmacotherapy;2023-07
4. Immunotherapy and Cancer Stem Cells;Molecular Targets and Cancer Therapeutics (Part 2);2023-04-19
5. Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates;Journal of Clinical Oncology;2023-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3